The Cooper Companies, Inc. (COO) Stock Analysis

Q: What is the COO stock price target?

Take-profit $81.96 (+33.4% upside). Prior stop was $58.39.

Recovery setup

SellModerate ConfidenceUpdated 15 hr ago (May 20, 2026, 1:41 AM ET)

Healthcare · Medical Instruments & Supplies

Sell if holding. Multiple concerning factors at $61.45: Consecutive earnings misses (2); Below 200-MA, MA slope -1.6%/30d (confirmed downtrend).

Cooper Companies operates CooperVision (global contact lens manufacturer) and CooperSurgical (fertility devices, IVF products, cord blood storage, and contraception), selling in 130+ countries. Approximately half of fiscal 2025 net sales came from outside the U.S. Some silicone... Read more

$61.45+33.4% A.UpsideScore 5.6/10#8 of 25 Medical Instruments & Supplies

QualityF-score8 / 9FCF yield3.09%

Stop $58.39Target $81.96(analyst − 10%)A.R:R 6.7:1

Analyst target$91.07+48.2%15 analysts

$81.96our TP

$61.45price

$91.07mean

$103

Sell if holding. Multiple concerning factors at $61.45: Consecutive earnings misses (2); Below 200-MA, MA slope -1.6%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 51. Score 5.6/10, moderate confidence.

Passes 8/10 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 16d clear, semi cycle peak clear, materials cycle peak clear). Suitability: moderate.

Recent Developments — The Cooper Companies, Inc.

Latest news

JANA Partners Increases Stake In Alkami Technology To 5,431,388 Shares; CooperCompanies To 3,565,158 Shares; Fiserv To 4 — benzinga May 15, 2026

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards

Sector modifier (Healthcare): +0.5

Analyst upside: 33%

Risks

Consecutive earnings misses (2)

Below 200-MA, MA slope -1.6%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)30.3

P/E (Fwd)12.1

Mkt Cap$11.9B

EV/EBITDA13.2

Profit Mgn9.7%

ROE4.9%

Rev Growth6.2%

Beta0.89

DividendNone

Rating analysts25

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.93bearish

IV47%normal

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

10 dimensions · all in-band

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value6.815%1.02

Quality5.615%0.84

Growth5.715%0.85

Momentum5.410%0.54

Sentiment6.510%0.65

Insider Activity5.010%0.50

Peer Rank4.310%0.43

Technical Setup5.45%0.27

Risk Profile6.45%0.32

Catalyst4.15%0.20

Overall (Σ contributions)5.63

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

GatesMomentum 5.4<5.5 (soft — BUY_NOW allowed but watch)Death cross (50MA < 200MA)Momentum 5.4>=4.5A.R:R 6.7 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 16d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Moderate

RSI

51 · Neutral

↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $58.89Resistance $68.02

Price Targets

$58

$82

A.Upside+33.4%

A.R:R6.7:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeRisk-Off

Risk Alerts

! NEWS_MOD=-1: HOLD_IF_HOLDING → SELL_IF_HOLDING

Earnings

2/4 beats

Next Earnings2026-06-04 (16d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is COO stock a buy right now?

Sell if holding. Multiple concerning factors at $61.45: Consecutive earnings misses (2); Below 200-MA, MA slope -1.6%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 51. Prior stop was $58.39. Score 5.6/10, moderate confidence.

What is the COO stock price target?

Take-profit target: $81.96 (+33.4% upside). Prior stop was $58.39. Stop-loss: $58.39.

What are the risks of investing in COO?

Consecutive earnings misses (2); Below 200-MA, MA slope -1.6%/30d (confirmed downtrend).

Is COO overvalued or undervalued?

The Cooper Companies, Inc. trades at a P/E of 30.3 (forward 12.1). TrendMatrix value score: 6.8/10. Verdict: Sell.

What do analysts say about COO?

25 analysts cover COO with a consensus score of 3.8/5. Average price target: $91.

What does The Cooper Companies, Inc. do?Cooper Companies operates CooperVision (global contact lens manufacturer) and CooperSurgical (fertility devices, IVF...